Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages 4276-4282

  Casson, Peter R ^a   Toth, Michael J ^a   Johnson, Julia V ^a   Stanczyk, Frank Z ^b   Casey, Colleen L ^a   Dixon, Marjorie E ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ANDROSTENETRIOL GLUCURONIDATE; PRASTERONE SULFATE; TESTOSTERONE; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ABDOMINAL OBESITY; ADULT; AEROBIC CAPACITY; AGED; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY FAT; COHORT ANALYSIS; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; METABOLIC REGULATION; MORPHOMETRICS; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; BLOOD; BODY WEIGHT; HEALTH; HEALTH STATUS INDICATOR; METABOLOME; MIDDLE AGED; PHYSIOLOGY; STATISTICS; STATISTICS AND NUMERICAL DATA;

AGED; ANDROGENS; BODY WEIGHTS AND MEASURES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH; HEALTH STATUS INDICATORS; HUMANS; IDEAL BODY WEIGHT; MALE; METABOLOME; MIDDLE AGED; POSTMENOPAUSE; STATISTICS AS TOPIC; TESTOSTERONE;

EID: 77956582083     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2390     Document Type: Article

References (40)

1. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ 2002 Testosterone administration to oldermenimproves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282:E601-E607
2. Bhasin S 2003 Effects of testosterone administration on fat distribution, insulin sensitivity, and atherosclerosis progression. Clin Infect Dis 37(Suppl 2):S142-S149 (Pubitemid 37102737)
3. Sites CK, L'Hommedieu GD, Toth MJ, Brochu M, Cooper BC, Fairhurst PA 2005 The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90:2701-2707 (Pubitemid 40686312)
4. Cooper BC, Sites CK, Casson PR, Toth MJ 2007 Ovarian suppression with gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril 87:1131-1138
5. Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE, Casson PR 2008 Role of ovarian hormones in the regulation of glucose homeostasis: effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab 294:E1035-E1045
6. Wilson CM, McPhaul MJ 1996 A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol 120:51-57
7. Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR 2001 Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med 10:785-795
8. Anderson LA, McTernan PG, Harte AL, Barnett AH, Kumar S 2002 The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes Metab 4:209-213
9. Sowers MF, Beebe JL, McConnell D, Randolph J, Jannausch M 2001 Testosterone concentrations in women aged 25-50 Years: associations with lifestyle, body composition, and ovarian status. Am J Epidemiol 153:256-264
10. Dobs AS, Nguyen T, Pace C, Roberts CP 2002 Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 87:1509-1516
11. Gruber DM, Sator MO, Kirchengast S, Joura EA, Huber JC 1998 Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women. Maturitas 29:253-259
12. Davis SR, McCloud P, Strauss BJ, Burger H 1995 Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21:227-236
13. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F 1996 Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150(Suppl):S43-S50
14. Villareal DT, Holloszy JO, Kohrt WM 2000 Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf) 53:561-568
15. Kritz-Silverstein D, Barrett-Connor E, Wingard DL 1997 Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health 57:676-680
16. Casson PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE, Buster JE 1995 Replacement of dehydroepiandrosterone (DHEA) enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 63:1027-1031
17. Bates Jr GW, Egerman RS, Umstot ES, Buster JE, Casson PR 1995 Dehydroepiandrosterone (DHEA) attenuates study-induced declines in insulin sensitivity in postmenopausal women. Ann NY Acad Sci 774:291-293
18. Villareal DT, Holloszy JO 2004 Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292:2243-2248
19. Dawson DA, Thompson GB 1987 Breast cancer risk factors and screening: United States, 1987. National Center for Health Statistics. Vital Health Stat Series 10, No. 172. Hyattsville, MD: Department of Health and Human Services
20. American College of Obstetricians and Gynecologists 1999 Prophylactic oophorectomy. ACOG practice bulletin No. 7. Washington, DC: American College of Obstetricians and Gynecologists
21. Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA 2002 Hysterectomy surveillance: United States, 1994-1999. MMWR Morb Mortal Wkly Rep 51 (SS05):1-8
22. Judd HL, Judd GE, Lucas WE, Yen SS 1974 Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 39:1020-1024
23. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS 2005 Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106:219-226
24. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE 2009 Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol 113:1027-1037
25. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H 2007 Utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405-413
26. 2 data. J Appl Physiol 75:2288-2292
27. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
28. Abumrad NN, Rabin D, Diamond MP, Lacy WW 1981 Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man. Metabolism 30:936-940
29. Toth MJ, Poehlman ET, Matthews DE, Tchernof A, MacCoss MJ 2001 Effect of estradiol and progesterone on body composition, protein synthesis and lipoprotein lipase in rats. American Journal of Physiology 280:E496-E501
30. Toth MJ, Poehlman ET, Matthews DE, Tchernof A, MacCoss MJ 2000 Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 24:226-231
31. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, Pierson Jr RN 1990 Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 52:214-218
32. Goebelsmann U, Arce JJ, Thorneycroft IH, Mishell Jr DR 1974 Serum testosterone levels in women throughout the menstrual cycle and following hCG administration. Am J Obstet Gynecol 119:445-452
33. Goebelsmann U, Bernstein GS, Gale JA, Kletzky OA, Nakamura RM, Coulson AH, Korelitz JJ 1979 Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. New York: Academic Press
34. Sodergard R, Backstrom T, Shanbhag V, Carstensen H 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma protein at body temperature. J Steroid Biochem 26:801-810
35. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
36. Rinaldi S, Geay A, Déchaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Riboli E, Toniolo P, Kaaks R 2002 Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 11:1065-1071
37. Dhatariya K, Bigelow ML, Nair KS 2005 Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 54:765-769
38. Sternfeld B, Liu K, Quesenberry Jr CP, Wang H, Jiang SF, Daviglus M, Fornage M, Lewis CE, Mahan J, Schreiner PJ, Schwartz SM, Sidney S, Williams OD, Siscovick DS 2008 Changes over 14 years in androgenicity and body mass index in a biracial cohort of reproductive-age women. J Clin Endocrinol Metab 93:2158-2165
39. Plymate SR, Matej LA, Jones RE, Friedl KE 1988 Inhibition of sex hormone binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67:460-464
40. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ 3rd, Smith GE, Khosla S, Jensen MD 2006 DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647-1659